| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | SVP, General Counsel | Common Stock | 313K | $1.53M | $4.88 | Mar 9, 2024 | Direct |
| Aquestive Therapeutics, Inc. | SVP, General Counsel | Performance Stock Units | 75K | Aug 9, 2023 | Direct | ||
| Aquestive Therapeutics, Inc. | SVP, General Counsel | Non-Qualified Stock Option (right to buy) | 67.5K | Mar 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Mar 9, 2024 | 1 | -$51.4K | 4 | Mar 12, 2024 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 11, 2024 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Aug 9, 2023 | 1 | $0 | 4 | Aug 9, 2023 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | May 5, 2023 | 1 | $0 | 4 | May 5, 2023 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 9, 2023 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Nov 4, 2022 | 1 | $0 | 4 | Nov 8, 2022 | SVP, General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Jun 8, 2022 | 2 | $15K | 4 | Jun 10, 2022 | General Counsel |
| AQST | Aquestive Therapeutics, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | SVP, General Counsel |